Rosacea – The Good, The Bad & The Red

Rosacea – The Good, The Bad & The Red

Summer is here and the heat can flair up a number of skin concerns… including rosacea. We asked Dr. Doris Day, dermatologist and Clinical Associate Professor, New York University Langone Medical Center, for details on this condition that affects about 16 million Americans. Are you one of them? Find out below…

Beauty Banter: What is Rosacea?
Dr. Doris Day: “Rosacea is a common, inflammatory skin condition that usually starts in your 20’s or 30’s. It’s often confused with acne but is a completely different condition. Persistent facial redness is the most common symptom of rosacea.”

BB: How do you know if you have rosacea?
Dr.DD: “Rosacea can vary from person to person. It is classified into four subtypes according to signs and symptoms that often occur together. It is possible to experience characteristics of more than one subtype. 
Common symptoms include: facial redness, bumps and pimples, skin thickening and eye irritation.”

BB: How can you treat rosacea?
Dr.DD: “If you think you have rosacea, it’s important to consult your dermatologist. If left untreated, rosacea may get worse, and it also has the ability to psychologically and emotionally impact your life. While there is no cure for rosacea, your dermatologist can help you control rosacea, by helping you to understand the triggers and providing you with prescription or in-office treatment for the symptoms. Mirvaso® (brimonidine) topical gel, 0.33%* can work in as little as 30 minutes, providing same-day results that last up to 12 hours before the persistent facial redness returns. It is the only FDA-approved treatment specifically designed and indicated for the persistent facial redness of rosacea.”

You can learn more about rosacea, read about treatment options and view skincare tips from Dr. Doris Day below. Be sure to enter for a chance to get red-carpet ready and enter for a chance to win a trip to the Emmys!

Important Safety Information
Indication:  Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.  Adverse Events:  In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis.  Warnings/Precautions:  Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.

About Beauty Banter
Beauty Banter was launched in July of 2006 as a comprehensive beauty blog covering trends, tips and tricks, insider secrets, and weekly must-haves. Beauty Banter has a reputation of being on the cutting edge of emerging trends and product launches so our readers are always the first to know what’s hot and what’s just not.